Dolutegravir Pregnancy and Breastfeeding Warnings

Dolutegravir is also known as: Tivicay

Dolutegravir Pregnancy Warnings

Animal studies have failed to reveal evidence of impaired fertility or fetal harm. Dolutegravir was shown to cross the placenta in animal studies. There are no controlled data in human pregnancy. A pregnancy registry has been established to monitor maternal-fetal outcomes of pregnant women with HIV exposed to dolutegravir and other antiretrovirals. Healthcare providers are encouraged to register patients by calling 1-800-258-4263 (USA). FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.

FDA pregnancy category: B Dolutegravir should be used during pregnancy only if clearly needed.

Dolutegravir Breastfeeding Warnings

Due to the potential for HIV transmission and the potential for adverse reactions in nursing infants, mothers should not breastfeed if taking dolutegravir. Excreted into human milk: Unknown Excreted into animal milk: Yes The US Centers for Disease Control and Prevention and the American Academy of Pediatrics advise HIV-1-infected women not to breastfeed to avoid postnatal transmission of HIV-1 to a child who may not yet be infected.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide
(web5)